Trans-cellular Propagation of Tau Aggregation by Fibrillar Species

Cited by (546)

Items 401–500 of 546

1. An mTOR-independent Macroautophagy Activator Ameliorates Tauopathy and Prionopathy Neurodegeneration Phenotypes
   Leonard Yoon, Rachel C. Botham, Adriaan Verhelle, Yin Wu, Christian M. Cole, Ee Phie Tan, Lynée A. Massey, Pablo Sanz-Martinez, Ching‐Chieh Chou, Jin Xu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
2. Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?
   Julia Sala‐Jarque, Karolina Zimkowska, Jesús Ávila, Isidró Ferrer, José Antonio del Rı́o · 2022 · International Journal of Molecular Sciences
3. Common and Specific Marks of Different Tau Strains Following Intra-Hippocampal Injection of AD, PiD, and GGT Inoculum in hTau Transgenic Mice
   Isidró Ferrer, Pol Andrés‐Benito, Margarita Carmona, José Antonio del Rı́o · 2022 · International Journal of Molecular Sciences
4. A robust yet simple method to generate fluorescent amyloid nanofibers
   Kailash Prasad Prajapati, Masihuzzaman Ansari, Deepak Yadav, Shikha Mittal, Bibin Gnanadhason Anand, Karunakar Kar · 2023 · Journal of Materials Chemistry B
5. A hydrocortisone derivative binds to GAPDH and reduces the toxicity of extracellular polyglutamine-containing aggregates
   Vladimir F. Lazarev, Elena R. Mikhaylova, Elizaveta A. Dutysheva, Roman Vladimirovich Suezov, Irina V. Guzhova, Boris A. Margulis · 2017 · Biochemical and Biophysical Research Communications
6. Multimodal 18F-AV-1451 and MRI Findings in Nonfluent Variant of Primary Progressive Aphasia: Possible Insights on Nodal Propagation of Tau Protein Across the Syntactic Network
   Belén Pascual, Quentin Funk, Paolo Zanotti‐Fregonara, Neha Pal, Elijah Rockers, Meixiang Yu, Bryan Spann, Gustavo C. Román, Paul Ernest Schulz, Christof Karmonik et al. · 2019 · Journal of Nuclear Medicine
7. Ubiquitination and SUMOylation of Amyloid and Amyloid-like Proteins in Health and Disease
   Lenzie K. Ford, Luana Fioriti, Eric R. Kandel · 2019 · Current Issues in Molecular Biology
8. Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
   Maksim I. Sulatsky, Olesya V. Stepanenko, Olga V. Stepanenko, Anna I. Sulatskaya · 2025 · Aggregate
9. Proximity Labeling of the Tau Repeat Domain Enriches RNA-Binding Proteins That Are Altered in Alzheimer's Disease and Related Tauopathies
   Sarah M. Shapley, Anantharaman Shantaraman, Joshna Dharmendrabhai Gadhavi, Masin A. Kearney, Eric B. Dammer, Duc M. Duong, Christine A Bowen, Caroline M Watson, Pritha Bagchi, Qi Guo et al. · 2025 · Molecular & Cellular Proteomics
10. Tracking tau and cellular responses in human iPSC‐microglia: from uptake to seedable secretion, including in extracellular vesicles
    Maria Kreger Karabova, Anna del Ser‐Badia, Anne Hedegaard, Sam J. Washer, Zeynep Baykam, Darragh Patrick O'Brien, Iolanda Vendrell, Svenja Hester, Roman Fischer, Errin Johnson et al. · 2026 · Alzheimer s & Dementia
11. Opportunities for Conformation-Selective Antibodies in Amyloid-Related Diseases
    Marta Westwood, Alastair D. G. Lawson · 2015 · Antibodies
12. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases
    Shun Yoshida, Takafumi Hasegawa · 2022 · Neurochemistry International
13. Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro
    Catherine Fressinaud, Joël Eyer · 2012 · Neurochemistry International
14. Spin Labeling and Characterization of Tau Fibrils Using Electron Paramagnetic Resonance (EPR)
    Virginia Meyer, Martin Margittai · 2015 · Methods in molecular biology
15. Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
    Andrea C. Klaver, Mary P. Coffey, David Alan Bennett, David A. Loeffler · 2017 · Translational Neurodegeneration
16. Alzheimer’s Disease and Dementia
    Patrick Alfryn Lewis, Jennifer E. Spillane · 2018 · Elsevier eBooks
17. Investigational therapeutics for the treatment of progressive supranuclear palsy
    David G. Coughlin, Irene Litvan · 2022 · Expert Opinion on Investigational Drugs
18. Amyloids on Membrane Interfaces: Implications for Neurodegeneration
    Amaresh Kumar Mahakud, Jafarulla Shaikh, V. V. Rifa Iqbal, Abhinav Gupta, Anuj Tiwari, Mohammed Saleem · 2022 · The Journal of Membrane Biology
19. β-Bracelets: Macrocyclic Cross-β Epitope Mimics Based on a Tau Conformational Strain
    Benjamin H. Rajewski, Kamlesh Madhusudan Makwana, Isaac J. Angera, Danielle K. Geremia, Anna R. Zepeda, Grace I. Hallinan, Rubén Vidal, Bernardino Francesco Ghetti, Arnaldo L. Serrano, Juan R. Del Valle · 2023 · Journal of the American Chemical Society
20. Prions and Non-infectious Amyloids of Mammals – Similarities and Differences
    Alexey P. Galkin, Maria E. Velizhanina, Julia V. Sopova, Aleksandr A. Shenfeld, Sergey P. Zadorsky · 2018 · Biochemistry (Moscow)
21. Lipid Nanoparticles Vectorized with NFL-TBS.40-63 Peptide Target Oligodendrocytes and Promote Neurotrophin-3 Effects After Demyelination In Vitro
    Catherine Fressinaud, Olivier Thomas, Anita Monika Umerska, Patrick Saulnier · 2020 · Neurochemical Research
22. Tau seeding activity in various regions of down syndrome brain assessed by two novel assays
    Nana Jin, Jianlan Gu, Ruozhen Wu, Dandan Chu, Yunn Chyn Tung, Jerzy Węgiel, Thomas Wısnıewskı, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2022 · Acta Neuropathologica Communications
23. Potential of Fluorescent Nanoprobe in Diagnosis and Treatment of Alzheimer’s Disease
    Jingjing Lin, Hanhan Li, Jingxuan Guo, Yue Xu, Hua Li, Jun Yan, Yuxin Wang, Haiyan Chen, Zhenwei Yuan · 2022 · Nanomedicine
24. The role of prion strain diversity in the development of successful therapeutic treatments
    Sara A. M. Holec, Alyssa J. Block, Jason C. Bartz · 2020 · Progress in molecular biology and translational science
25. Development of P301S tau seeded organotypic hippocampal slice cultures to study potential therapeutics
    James M. McCarthy, Jasmeet K. Virdee, Jessica Brown, Daniel Ursu, Zeshan Ahmed, Annalisa Cavallini, Hugh Norman Nuthall · 2021 · Scientific Reports
26. The tauopathies: Neuroimaging characteristics and emerging experimental therapies
    Kalen J. Riley, Brian D. Graner, Michael C. Veronesi · 2022 · Journal of Neuroimaging
27. Recent progress in prion and prion-like protein aggregation
    Chuan-Wei Yi, Wen-Chang Xu, Jie Chen, Yi Liang · 2013 · Acta Biochimica et Biophysica Sinica
28. Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation
    Kerry T. Sun, Tark Patel, Sang‐Gyun Kang, Allan Yarahmady, Mahalashmi Srinivasan, Olivier Julien, Jónathan Heras, Sue‐Ann Mok · 2023 · ACS Chemical Neuroscience
29. Tau in Multiple Sclerosis: A Review of Therapeutic Potential
    Carolin Luisa Hoehne, Olaf Stüve, Barbara Elena Stopschinski · 2025 · Current Treatment Options in Neurology
30. PseudoSorter: A self-supervised spike sorting approach applied to reveal Tau-induced reductions in neuronal activity
    Marius Brockhoff, Jakob Träuble, Sagnik Middya, Tanja Fuchsberger, Ana Fernández‐Villegas, Amberley D. Stephens, Miranda Robbins, Wenyue Dai, Belquis Haider, Sulay Vora et al. · 2025 · Science Advances
31. The engagement of microglia in tau-targeted immunotherapy in Alzheimer’s disease
    Denisa Palova, Natalia Turic Csokova, Karina Markova, Eva Kontseková, Branislav Kováčech, Monika Žilková · 2021 · General Physiology and Biophysics
32. Single Mutations in Tau Modulate the Populations of Fibril Conformers through Seed Selection
    Virginia Meyer, Paul D. Dinkel, Yin Luo, Xiang Yu, Guanghong Wei, Jie Zheng, Gareth R. Eaton, Buyong Ma, Ruth Nussinov, Sandra S. Eaton et al. · 2014 · Angewandte Chemie
33. Detection of Glymphatic Outflow of Tau from Brain to Cerebrospinal Fluid in Mice
    Kazuhisa Ishida, Kaoru Yamada · 2024 · Methods in molecular biology
34. Review—Recent Advancements in Neuroelectrochemistry of Disease Biomarkers
    Tyra Lewis, Sarah J. Lucas, Sanela Martić · 2019 · Journal of The Electrochemical Society
35. Ways to stop the spread of Alzheimer’s disease
    Moheb Costandi · 2018 · Nature
36. Synaptic distributions of pS214‐tau in rhesus monkey prefrontal cortex are associated with spine density, but not with cognitive decline
    Johanna L. Crimins, Rishi Puri, Katina C. Calakos, Frank Yuk, William G.M. Janssen, Yuko Hara, Peter R. Rapp, John H. Morrison · 2018 · The Journal of Comparative Neurology
37. Network activity changes in the pathophysiology of Alzheimer’s disease: the role of aging and early entorhinal cortex dysfunction
    Sharay E. Setti, Miranda N. Reed · 2021 · Metabolic Brain Disease
38. Following the pathway to Alzheimer’s disease
    William J. Jagust · 2018 · Nature Neuroscience
39. Alzheimer disease-associated tau post-translational modification mimics impact tau propagation and uptake
    John R. Dickson, Robert G R Sobolewski, Analiese R. Fernandes, Joanna M. Cooper, Zhanyun Fan, Mirra Chung, Cameron Donahue, Derek H. Oakley, Dudley K. Strickland, Bradley T. Hyman · 2025 · Journal of Neuropathology & Experimental Neurology
40. Nasal Extracts from Patients with Alzheimer’s Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation
    Aslina Pahrudin Arrozi, Daijiro Yanagisawa, Tomoko Kato, Hiroyasu Akatsu, Yoshio Hashizume, Daita Kaneda, Ikuo Tooyama · 2021 · Journal of Alzheimer s Disease Reports
41. NMR Relaxation Experiments Probe Monomer–Fibril Interaction and Identify Critical Interacting Residues Responsible for Distinct Tau Fibril Morphologies
    Muhammed Shafeek Oliyantakath Hassan, Arshad Abdul Vahid, Allwin Ebenezer Sahayaraj, Renjith Viswanathan, Vinesh Vijayan · 2023 · The Journal of Physical Chemistry Letters
42. Genetics of Frontotemporal Dementia
    Sasja Heetveld, Patrizia Rizzu, Peter Heutink · 2015 · Springer eBooks
43. Dale Schenk One Year Anniversary: Fighting to Preserve the Memories
    Cassia Overk, Eliezer Masliah · 2018 · Journal of Alzheimer s Disease
44. Frontotemporal dementia
    Eline Wauters, Kristel Sleegers, Marc Cruts, Christine Van Broeckhoven · 2017 · Elsevier eBooks
45. An autopsy case of progressive supranuclear palsy treated with monoclonal antibody against tau
    Goichi Beck, Rika Yamashita, Kansuke Kido, Kensuke Ikenaka, Tomoya Chiba, Yuki Yonenobu, Yuko Saito, Eiichi Morii, Masato Hasegawa, Shigeo Murayama et al. · 2023 · Neuropathology
46. α‐Synuclein Drives Tau's Cytotoxic Aggregates Formation through Hydrophobic Interactions
    Ana M. Ojeda, Valentina Cofré, Francisco Melo, Leonardo Caballero, Denis Fuentealba, Alberto Cornejo · 2023 · ChemPlusChem
47. “Proteinjury”: a universal pathological mechanism mediated by cerebrospinal fluid in neurodegeneration and trauma
    Vladimir F. Lazarev, Bashar A. Alhasan, Irina V. Guzhova, Boris A. Margulis · 2025 · Frontiers in Cell and Developmental Biology
48. Pathology and pathophysiology
    Bradford Clark Dickerson · 2015 · Cambridge University Press eBooks
49. Single cell transcriptomic profiling of neurodegeneration mediated by tau in a novel 3D neuron‐astrocyte coculture model
    Hannah Rickner, Lulu Jiang, Rui Hong, Nicholas K. O’Neill, Benjamin L. Wolozin, Christine S. Cheng · 2021 · Alzheimer s & Dementia
50. Cyclic-NDGA Effectively Inhibits Human γ-Synuclein Fibrillation, Forms Nontoxic Off-Pathway Species, and Disintegrates Preformed Mature Fibrils
    Sneh Lata Singh, Rajiv Bhat · 2024 · ACS Chemical Neuroscience
51. The formation of small aggregates contributes to the neurotoxic effects of tau45-230
    Sana Afreen, Adriana Ferreira · 2021 · Neurochemistry International
52. Genetic risk factors of Alzheimer's disease and cell-to-cell transmission of Tau
    Henri J. Huttunen · 2016 · Journal of Neurology and Neuromedicine
53. Minimalistic in vitro systems for investigating tau pathology
    Grace I. Hallinan, Aleksandra P. Pitera, Prutha Patel, Jonathan J. West, Katrin Deinhardt · 2018 · Journal of Neuroscience Methods
54. Conformational dynamics of Tau in the cell quantified by an intramolecular FRET biosensor in physiological and pathological context
    Cristina Di Primio, Valentina Quercioli, Giacomo Siano, Branislav Kováčech, M Novák, Antonino Cattaneo · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
55. Basal forebrain volume reliably predicts the cortical spread of Alzheimer’s degeneration
    Sara Fernández-Cabello, Martin Kronbichler, Koene R. A. Van Dijk, James A. Goodman, R. Nathan Spreng, Taylor W. Schmitz, Alzheimer’s Disease Neuroimaging Initiative · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
56. Passaging Human Tauopathy Patient Samples in Cells Generates Heterogeneous Fibrils with a Subpopulation Adopting Disease Folds
    Zhikai Zeng, Karen Tsay, Vishnu Vijayan, Matthew P. Frost, Shikhar Prakash, Athena Quddus, Alexa Albert, Michael P. Vigers, Madhur Srivastava, Amanda L. Woerman et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
57. Central and peripheral tau retention modulated by an anti-tau antibody
    Alexander G. Solorzano, Molly Brady, Nemil N. Bhatt, Angelique Johnson, Brooke Burgess, Hannah Leyva, Nicha Puangmalai, Cynthia Jerez, Ronald W. Wood, Rakez Kayed et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
58. Multimodal spatial gradients to explain regional susceptibility to fibrillar tau in Alzheimer's disease
    Ying Luan, Lukai Zheng, J. Denecke, Amir Dehsarvi, Sebastian Niclas Roemer, Anna Dewenter, Anna Steward, Sergey Shcherbinin, Diana Otero Svaldi, Vikas Kotari et al. · 2025 · Alzheimer s & Dementia
59. Tau Immunotherapy
    Einar M. Sigurdsson · 2016 · Methods in pharmacology and toxicology
60. Immunotherapeutics for AD: A Work in Progress
    Anuja Sharma, Jaspreet Singh Anand, Yatender Kumar · 2021 · CNS & Neurological Disorders - Drug Targets
61. Dementias
    Kimiko Domoto‐Reilly, Margaret E. Flanagan, Thomas J. Grabowski · 2019 · Springer eBooks
62. The multitude of therapeutic targets in neurodegenerative proteinopathies
    Ronald Melki · 2017 · Elsevier eBooks
63. Tauopathy Mouse Models
    Yan Ren, Naruhiko Sahara, Benoit I. Giasson, Jada M. Lewis · 2014 · Elsevier eBooks
64. Prion-Like Propagation in Neurodegenerative Diseases
    Wouter Peelaerts, Veerle Baekelandt, Patrik Brundin · 2018 · Elsevier eBooks
65. Defining the EM-signature of successful cell-transfection
    Joshua G. Pemberton, Tatyana I. Tenkova, Philip Louis Felgner, Joshua J. Zimmerberg, Tamás Balla, John E. Heuser · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
66. A high-throughput drug screening assay for anti-tau aggregation using split GFP and flow cytometry
    Omnia M. H. Ibrahium, Taiwo Ademola Ademoye, Jessica S. Fortin, Raluca Ostafe · 2025 · Scientific Reports
67. MAPT splicing modulators reduce 4R tau and rescue tauopathy phenotypes in human neurons and in a mouse model
    M. Catarina Silva, Hannah Lindmeier, Paolo Pigini, Jennifer Laughlin, Yong Yu, Christie Morrill, Michael A. Arnold, Scott J. Barraza, Khalil Saadipour, Monal Dieterich et al. · 2026 · Science Translational Medicine
68. Propriétés infectieuses des agrégats de protéines impliquées dans des maladies neurodégénératives
    Luc Bousset, Ronald Melki · 2013 · Biologie Aujourd hui
69. Methods and Protocols for Developing Prion Vaccines
    Kristen Marciniuk, Ryan Taschuk, Scott Napper · 2016 · Methods in molecular biology
70. Co-culture of Murine Neurons Using a Microfluidic Device for The Study of Tau Misfolding Propagation
    Grace I. Hallinan, Dianne Marquez Lopez, Mariana Vargas‐Caballero, Jonathan J. West, Katrin Deinhardt · 2020 · BIO-PROTOCOL
71. Tau Pathology in Neurodegenerative Diseases
    Thomas Vogels, Tomáš Hromádka · 2021 · Neuromethods
72. Frontotemporal lobar degeneration
    Boram Kim, Ashley Viera-Ortiz, Jessica M. Phan, David John Irwin, Edward B. Lee · 2022 · Elsevier eBooks
73. DES-Amyloidoses “Amyloidoses through the looking-glass”: A knowledgebase developed for exploring and linking information related to human amyloid-related diseases
    Vladan Bajić, Adil Salhi, Katja Lakota, Aleksandar Radovanović, Rozaimi Razali, Lada Živković, Biljana Spremo‐Potparević, Mahmut Uludağ, Faroug Tifratene, Olaa Motwalli et al. · 2022 · PLoS ONE
74. Passive Immunotherapy for Tau Pathology
    Peter Davies · 2016 · Elsevier eBooks
75. Preclinical models of Alzheimer’s disease for identification and preclinical validation of therapeutic targets: from fine-tuning strategies for validated targets to new venues for therapy
    Bruno Vasconcelos, Matthew Bird, Ilie‐Cosmin Stancu, Dick Terwel, Ilse Dewachter · 2017 · Elsevier eBooks
76. An In Vitro Model for Studying Tau Aggregation Using Lentiviral-mediated Transduction of Human Neurons
    Brent D. Aulston, Qing Liu, Patrick Reilly, Shauna H. Yuan · 2019 · Journal of Visualized Experiments
77. Alzheimer’s Disease
    Joshua H. K. Tam, Stephen Pasternak · 2017 · Elsevier eBooks
78. Tau-Centric Therapies for Treating Alzheimer’s Disease
    Shmma Quraishe, C.M. Cowan, Amritpal K. Mudher · 2017 · Elsevier eBooks
79. Prions as Non-Canonical Hereditary Factors
    O. N. Tikhodeyev · 2022 · Russian Journal of Genetics
80. Hexagonal Boron Nitride Nanoparticles for Inhibition of Small Fragment Tau Aggregation
    Srijita Paul, Lalitha Guruprasad · 2025 · The Journal of Physical Chemistry B
81. APP E590D mutation increases generation of Aβ and Aη peptides and exacerbates tauopathy
    Tian Liu, Liam Wetzel, David Roy, Kexin Zhang, Zexi Zhu, Pavan Kumaraguru, Viraj Gorthi, Hanna Jeon, Jung A. Woo, David E. Kang · 2026 · npj Dementia
82. Loss of endogenous tau suppresses APOE4-induced patterned behavioral decline and axon dysmorphia in a model of Alzheimer's disease
    Eric Andrew Cardona, Chelsea Joy Webber, Zheng Wu, Blythe Bolton, Elif Sarinay Cenik, Jonathan T. Pierce-Shimomura · 2026 · Disease Models & Mechanisms
83. Conformation-Dependent Antibodies as Tools for Characterization of Amyloid Protein Aggregates
    Jessica Wu, Leonid Breydo · 2013 · Elsevier eBooks
84. Tau-er of Power.
    Kenneth S. Kosik · 2015 · Europe PMC (PubMed Central)
85. Is it Premature to assume that Prion-like Propagation of Protein Misfolding is the Universal Model of Lesion Spread in Neurodegeneration?
    Garth F Hal · 2012 · Journal of Alzheimer’s Disease & Parkinsonism
86. Sleep Disorders and Dementia: From Basic Mechanisms to Clinical Decisions
    Elissaios Karageorgiou, Christine M. Walsh, Kristine S. Yaffe, Thomas C. Neylan, Bruce L. Miller · 2017 · Psychiatric Annals
87. Tau Aggregation, Conformational Selection, and Inhibition
    Michael R. Holden · 2018 · Digital Commons - DU (University of Denver)
88. Ubiquitination and SUMOylation of Amyloid and Amyloid-like Proteins in Health and Disease
    Lenzie K. Ford, Luana Fioriti, Eric R. Kandel · 2019 · Caister Academic Press eBooks
89. Two simple assays for assessing the seeding activity of proteopathic tau
    Fei Liu, Ruozhen Wu, Nana Jin, Dandan Chu, Jianlan Gu, Yunn Chyn Tung, Zhihao Hu, Cheng‐Xin Gong, Khalid Iqbal · 2023 · Frontiers in Aging Neuroscience
90. Dissecting membrane interfacial cellular processes: an in vitro reconstitution approach
    Ayush Panda, Amaresh Kumar Mahakud, Amit Beniwal, Barsha Rani Pradhan, Mohammed Saleem · 2024 · The European Physical Journal Special Topics
91. Faculty Opinions recommendation of Tau kinetics in neurons and the human central nervous system.
    Mark John Millan · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
92. Tamping down TAU
    Lauren Martz · 2013 · Science-Business eXchange
93. Functional implications of tau-fyn interactions in Alzheimer's disease
    Hay Wun Dawn Lau · 2015
94. Protein Misfolding and Amyloid Formation in Alzheimer’s Disease
    Iftikhar Aslam Tayubi, Ahmad Firoz, Adeel Malik · 2015 · Springer eBooks
95. Pathophysiologyand animal models of frontotemporal dementia
    Brian A. Warmus, Erik D. Roberson · 2015 · Cambridge University Press eBooks
96. Protein Aggregation and Neurodegeneration: Tauopathies and Synucleinopathies
    Michel Goedert · 2017 · Neurodegeneration
97. Engineering antibody therapeutics and cell culture models for neurodegenerative diseases
    Kyle P. McHugh · 2024 · Library, Museums and Press - UDSpace (University of Delaware)
98. Tau-Directed Immunotherapy for Alzheimer's Disease
    Sulana Kay Schroeder · 2017 · Digital Commons - University of South Florida (University of South Florida)
99. Optimization and Utilization of Hybrid Culture Between Rat and Fly Primary Neurons: A Novel Model for Studying Neurodegenerative Diseases
    Kimberly L. Kraus · 2016 · OhioLink ETD Center (Ohio Library and Information Network)
100. Development and characterization of cell models of tau aggregation
     Annalisa Cavallini · 2018 · UCL Discovery (University College London)